Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Clinical characteristics and outcome of isolated extramedullary relapse in acute leukemia after allogeneic stem cell transplantation: a single-center analysis.

Shi JM, Meng XJ, Luo Y, Tan YM, Zhu XL, Zheng GF, He JS, Zheng WY, Xie WZ, Li L, Ye XJ, Zhang J, Cai Z, Lin MF, Huang H.

Leuk Res. 2013 Apr;37(4):372-7. doi: 10.1016/j.leukres.2012.12.002. Epub 2013 Jan 21.

PMID:
23347901
2.

Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.

Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E.

Cancer. 1999 Feb 1;85(3):608-15. Review.

PMID:
10091734
3.

Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.

Solh M, DeFor TE, Weisdorf DJ, Kaufman DS.

Biol Blood Marrow Transplant. 2012 Jan;18(1):106-12. doi: 10.1016/j.bbmt.2011.05.023. Epub 2011 Jun 12.

4.

Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.

Lee KH, Lee JH, Choi SJ, Lee JH, Kim S, Seol M, Lee YS, Kim WK, Seo EJ, Park CJ, Chi HS, Lee JS.

Bone Marrow Transplant. 2003 Oct;32(8):835-42.

PMID:
14520431
5.

Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.

Barrios M, Jiménez-Velasco A, Román-Gómez J, Madrigal ME, Castillejo JA, Torres A, Heiniger A.

Haematologica. 2003 Jul;88(7):801-10.

6.

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

Pawson R, Potter MN, Theocharous P, Lawler M, Garg M, Yin JA, Rezvani K, Craddock C, Rassam S, Prentice HG.

Br J Haematol. 2001 Dec;115(3):622-9.

PMID:
11736947
8.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.

Biol Blood Marrow Transplant. 2008 Jun;14(6):685-92. doi: 10.1016/j.bbmt.2008.03.011.

9.

Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.

Ocheni S, Iwanski GB, Schafhausen P, Zander AR, Ayuk F, Klyuchnikov E, Zabelina T, Fiedler W, Schnittger S, Hochhaus A, Brümmendorf TH, Kröger N, Bacher U.

Leuk Lymphoma. 2009 Apr;50(4):551-8. doi: 10.1080/10428190902755513.

PMID:
19373652
10.

Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.

Lee JH, Choi SJ, Lee JH, Seol M, Lee YS, Ryu SG, Park CJ, Chi HS, Lee MS, Yun S, Lee JS, Lee KH.

Haematologica. 2005 Oct;90(10):1380-8.

11.

Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation.

Schmidt-Hieber M, Blau IW, Richter G, Türkmen S, Bommer C, Thiel G, Neitzel H, Stroux A, Uharek L, Thiel E, Blau O.

Cancer Genet Cytogenet. 2010 Apr 15;198(2):135-43. doi: 10.1016/j.cancergencyto.2010.01.005. Erratum in: Cancer Genet Cytogenet. 2010 Jul 1;200(1):73.

PMID:
20362228
12.

Repeated relapses of acute myelogenous leukemia in the isolated extramedullary sites following allogeneic bone marrow transplantations.

Kikushige Y, Takase K, Sata K, Aoki K, Numata A, Miyamoto T, Fukuda T, Gondo H, Harada M, Nagafuji K.

Intern Med. 2007;46(13):1011-4. Epub 2007 Jul 2.

13.

High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation.

Lee KH, Lee JH, Kim S, Lee JS, Kim SH, Kim WK.

Bone Marrow Transplant. 2000 Jul;26(2):147-52.

14.

Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.

Yoshihara T, Morimoto A, Kuroda H, Imamura T, Ishida H, Tsunamoto K, Naya M, Hibi S, Todo S, Imashuku S.

Bone Marrow Transplant. 2006 Jan;37(1):25-31.

PMID:
16247416
15.

Unusual presentation of central nervous system relapse with oculomotor nerve palsy in a case of CD56-positive acute myeloid leukemia following allogeneic stem cell transplantation.

Haase R, Wiegand P, Hirsch W, Meyer-Bahlburg A, Diwan O, Wawer A, Burdach S.

Pediatr Transplant. 2002 Jun;6(3):260-5.

PMID:
12100514
16.

Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.

Lazzarotto D, Candoni A, Filì C, Forghieri F, Pagano L, Busca A, Spinosa G, Zannier ME, Simeone E, Isola M, Borlenghi E, Melillo L, Mosna F, Lessi F, Fanin R.

Leuk Res. 2017 Feb;53:74-81. doi: 10.1016/j.leukres.2016.12.003. Epub 2016 Dec 20.

PMID:
28056398
17.

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

Wahlin A, Billström R, Björ O, Ahlgren T, Hedenus M, Höglund M, Lindmark A, Markevärn B, Nilsson B, Sallerfors B, Brune M.

Eur J Haematol. 2009 Aug;83(2):99-107. doi: 10.1111/j.1600-0609.2009.01256.x. Epub 2009 Apr 6.

PMID:
19385987
18.

Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.

Slavin S, Naparstek E, Nagler A, Ackerstein A, Samuel S, Kapelushnik J, Brautbar C, Or R.

Blood. 1996 Mar 15;87(6):2195-204.

19.

A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of cytogenetic characteristics on transplantation outcome.

Fung HC, Stein A, Slovak Ml, O'donnell MR, Snyder DS, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E, Forman SJ.

Biol Blood Marrow Transplant. 2003 Dec;9(12):766-71.

20.

Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment.

Blaise DP, Michel Boiron J, Faucher C, Mohty M, Bay JO, Bardoux VJ, Perreau V, Coso D, Pigneux A, Vey N.

Cancer. 2005 Nov 1;104(9):1931-8.

Supplemental Content

Support Center